SlideShare a Scribd company logo
8/26/14
1
Agenda	
  
•  Icebreaker	
  
•  Drug	
  informa1on	
  references	
  
– Categories	
  of	
  drug	
  informa1on	
  literature	
  
•  Advantages	
  vs.	
  Disadvantages	
  
•  Examples	
  
– Some	
  commonly	
  used	
  resources	
  
•  Poten1al	
  topics	
  for	
  future	
  webinars	
  
Icebreaker	
  
•  Presenters	
  
– Võ	
  Thị	
  Hà,	
  MSPharm.	
  
– Nguyễn	
  Như	
  Hồ,	
  MSPharm.	
  
– Nguyễn	
  Đức	
  Như	
  Khuê,	
  PharmD/MPH	
  
•  ASendees	
  
To	
  Wiki	
  or	
  Not	
  to	
  Wiki?	
   Categories	
  of	
  Drug	
  Informa6on	
  Literature	
  
• Primary	
  literature	
  
• Secondary	
  literature	
  
• Ter1ary	
  literature	
  
Primary	
  Literature	
  
•  Original	
  “research”	
  publica1ons.	
  
•  Source	
  of	
  informa1on	
  for	
  the	
  development	
  of	
  the	
  
secondary	
  and	
  ter1ary	
  literature.	
  
•  Containing	
  a	
  detailed	
  descrip1on	
  of	
  study	
  design,	
  
methodology,	
  and	
  results.	
  
•  Research	
  studies,	
  case	
  reports,	
  editorials,	
  disserta1ons,	
  
leSers	
  to	
  the	
  editor,	
  and	
  randomized	
  control	
  trials	
  
published	
  or	
  presented	
  for	
  the	
  first	
  1me.	
  
•  Top	
  1er	
  peer	
  reviewed	
  journals:	
  NEJM,	
  JAMA,	
  Archives	
  
of	
  Internal	
  Medicine,	
  BMJ,	
  Pharmacotherapy,	
  Lancet,	
  
etc…	
  	
  
Primary	
  Literature	
  (cont.)	
  
•  Advantages:	
  
– Current,	
  original,	
  and	
  "cucng-­‐edge"	
  informa1on.	
  	
  
– Pa#ent-­‐oriented	
  &	
  evidence-­‐based	
  medicine	
  that	
  can	
  
be	
  directly	
  u#lized	
  to	
  help	
  care	
  for	
  pa#ents.	
  
– Peer	
  reviewed,	
  unbiased	
  sugges1ons,	
  and	
  open	
  to	
  
cri1ques	
  and	
  rebuSals.	
  
•  Disadvantages:	
  
– Inaccurate	
  conclusions	
  d/t	
  flaws	
  in	
  methodology	
  
– Improper	
  interpreta1on	
  d/t	
  lack	
  of	
  knowledge	
  about	
  
scien1fic	
  methods	
  and	
  sta1s1cs	
  
– Time	
  for	
  new	
  informa1on	
  to	
  be	
  widely	
  accepted	
  
8/26/14
2
Primary	
  Literature	
  in	
  Prac6ce	
  
•  Learn	
  to	
  be	
  cau1ous	
  with	
  new	
  informa1on.	
  
•  Is	
  the	
  ar1cle	
  from	
  a	
  peer-­‐reviewed	
  journal?	
  	
  
•  Understand	
  study	
  popula1on,	
  methods,	
  
sta1s1cal	
  and	
  clinical	
  relevance	
  	
  to	
  your	
  prac1ce	
  
popula1on	
  before	
  extrapola1ng	
  to	
  your	
  pa1ent.	
  
•  Remember	
  case	
  reports	
  relate	
  only	
  to	
  one	
  
pa1ent,	
  watch	
  for	
  bias,	
  and	
  avoid	
  relying	
  on	
  
anecdotes.	
  
Secondary	
  Literature	
  
•  Indexing	
  and	
  abstrac1ng	
  services.	
  
•  Examples:	
  
– Medline	
  Database	
  covers	
  many	
  fields	
  of	
  medicine	
  
including:	
  den1stry,	
  nursing,	
  veterinary,	
  pharmacy	
  
and	
  hard	
  sciences.	
  
•  PubMed	
  Medline	
  
•  OVID	
  Medline	
  
– Iowa	
  Drug	
  Informa6on	
  Service	
  indexes	
  English	
  
(full	
  text)	
  ar1cles	
  relevant	
  to	
  drugs	
  and	
  treatment	
  
of	
  disease	
  from	
  approximately	
  200	
  journals.	
  
– Micromedex:	
  an	
  extensive	
  pharmacology	
  
database	
  
Secondary	
  Literature	
  (cont.)	
  
•  Advantages:	
  
– Quick	
  access	
  to	
  the	
  primary	
  literature.	
  
– Large	
  scope	
  of	
  and/or	
  concise	
  informa1on	
  on	
  
specific	
  topics	
  
– Generally	
  from	
  peer	
  reviewed	
  and	
  high	
  standard	
  
journal	
  sources.	
  
•  Disadvantages:	
  
– Lag	
  1me	
  
– Availability	
  of	
  specific	
  journal	
  
– Large	
  amount	
  of	
  informa1on	
  –	
  Search	
  techniques	
  
– Cost	
  
Ter6ary	
  Literature	
  
•  Textbooks	
  e.g.	
  Goodman	
  &	
  Gilman’s	
  
Pharmacological	
  Basis	
  of	
  Therapeu1cs	
  
•  Compendia	
  (a	
  vast	
  array	
  of	
  informa1on	
  about	
  
many	
  drugs)	
  e.g.	
  such	
  as	
  Facts	
  and	
  Comparisons	
  
•  Review	
  ar1cles	
  in	
  journals	
  that	
  thoroughly	
  
summarize	
  a	
  par1cular	
  topic	
  can	
  also	
  be	
  
considered	
  ter1ary	
  literature	
  (usually	
  more	
  up	
  to	
  
date	
  than	
  text)	
  
Ter6ary	
  Literature	
  (cont.)	
  
•  Advantages:	
  
– Convenient	
  and	
  easy	
  to	
  use.	
  	
  	
  
– Divided	
  into	
  specific	
  subjects,	
  e.g.	
  drug	
  
interac1ons,	
  drugs	
  in	
  pregnancy.	
  
– Informa1on	
  generally	
  well	
  accepted	
  
•  Disadvantages:	
  
– Lag	
  1me	
  
– Space	
  limita1on	
  
– Less	
  thorough	
  review	
  
– Possible	
  inappropriate	
  references	
  
– Flawed	
  primary	
  literature	
  (poorly	
  done	
  studies)	
  
Common	
  Online	
  Sources	
  (in	
  US)	
  
•  FDA	
  approved	
  drug	
  products:	
  
www.accessdata.fda.gov/scripts/cder/drugsarda	
  
•  Dailymed	
  @	
  NLM	
  (database	
  of	
  product	
  package	
  inserts)	
  :	
  
www.dailymed.nlm.nih.gov/dailymed	
  	
  
•  Drug	
  informa1on	
  portal	
  @	
  NLM:	
  
www.druginfo.nlm.nih.gov/drugportal	
  	
  
•  Consumer	
  page	
  @	
  FDA:	
  www.fda.gov/forconsumers	
  
•  MedlinePlus	
  @	
  NIH:	
  www.nlm.nih.gov/medlineplus	
  
•  FDA	
  medica1on	
  guides:	
  www.fda.gov/drugs/drugsafety/	
  
•  MedWatch:	
  www.fda.gov/safety/medwatch	
  
•  Medica1on	
  safety:	
  www.ismp.org	
  	
  
•  Drug	
  iden1fica1on:	
  pillbox.nlm.nih.gov	
  	
  
8/26/14
3
Common	
  Online	
  Sources	
  (in	
  US)	
  
•  Diseases	
  &	
  Condi1ons	
  @	
  CDC:	
  
www.cdc.gov/diseasescondi1ons	
  
•  Travel	
  medicine:	
  www.cdc.gov/travel	
  or	
  www.iamat.org	
  	
  
•  Na1onal	
  guideline	
  clearinghouse:	
  www.guideline.gov	
  
•  Clinical	
  trials:	
  www.clinicaltrials.gov	
  
•  Na1onal	
  Cancer	
  Ins1tute:	
  www.cancer.gov	
  
•  Most	
  of	
  cancer	
  guidelines:	
  www.nccn.org	
  	
  
•  DM	
  guideline:	
  ADA	
  2013	
  (less	
  commonly	
  used	
  AACE)	
  
•  HTN:	
  JNC	
  8	
  or	
  AHA	
  for	
  HTN	
  
•  An1thrombo1c	
  therapy:	
  CHEST	
  2012	
  
•  Dyslipidemia:	
  AHA/ACC	
  2013	
  Cholesterol	
  (aka	
  “ATP	
  4”)	
  
•  Be	
  proac1ve:	
  look	
  for	
  drug	
  problems.	
  	
  No	
  other	
  healthcare	
  
provider	
  has	
  the	
  unique	
  opportunity	
  to	
  improve	
  drug	
  therapy	
  
that	
  pharmacists	
  have.	
  
•  Dig	
  deeper:	
  oxen	
  1mes	
  the	
  ques1on	
  that	
  is	
  originally	
  asked	
  is	
  
not	
  the	
  ques1on	
  the	
  person	
  was	
  trying	
  to	
  ask.	
  
•  Be	
  skillful:	
  use	
  a	
  systema1c,	
  logical,	
  organized	
  approach.	
  
•  Keep	
  records:	
  document	
  your	
  search	
  methods	
  and	
  answer.	
  
•  There	
  may	
  be	
  more	
  than	
  one	
  correct	
  answer.	
  	
  	
  
•  An	
  acceptable	
  answer	
  may	
  be	
  “I	
  will	
  find	
  out”.	
  
Drug	
  Informa1on	
  Pearls	
  

More Related Content

Similar to Slide_Drug information_PharmD Khuê

Clinical Tools - Faculty Development
Clinical Tools - Faculty DevelopmentClinical Tools - Faculty Development
Clinical Tools - Faculty DevelopmentRobin Featherstone
 
Systematic approach in answering DI queries request
Systematic approach in answering   DI queries requestSystematic approach in answering   DI queries request
Systematic approach in answering DI queries requestKhadga Raj
 
P1_DI-Principles-and-Practice_student-version.pptx
P1_DI-Principles-and-Practice_student-version.pptxP1_DI-Principles-and-Practice_student-version.pptx
P1_DI-Principles-and-Practice_student-version.pptxDascoKenya
 
Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Ann-Marie Roche
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
poison and drug info.pdf
poison and drug info.pdfpoison and drug info.pdf
poison and drug info.pdfAmeena Kadar
 
Literature monitoring for pharmacovigilance – outsourcing or in house solution
Literature monitoring for pharmacovigilance – outsourcing or in house solutionLiterature monitoring for pharmacovigilance – outsourcing or in house solution
Literature monitoring for pharmacovigilance – outsourcing or in house solutionJulio dos Anjos
 
NCompass Live: PubMed, PubMed Central, MEDLINE, MedlinePlus...What's the diff...
NCompass Live: PubMed, PubMed Central, MEDLINE, MedlinePlus...What's the diff...NCompass Live: PubMed, PubMed Central, MEDLINE, MedlinePlus...What's the diff...
NCompass Live: PubMed, PubMed Central, MEDLINE, MedlinePlus...What's the diff...Nebraska Library Commission
 
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη ΦαρμακοεπιδημιολογίαΗ συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη ΦαρμακοεπιδημιολογίαEvangelos Fragkoulis
 
Library resources for clinical faculty
Library resources for clinical facultyLibrary resources for clinical faculty
Library resources for clinical facultyKristin Kroger
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug informationSumit Kumar
 
How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...jangeissler
 
Mobilizing informational resources for rare diseases
Mobilizing informational resources for rare diseasesMobilizing informational resources for rare diseases
Mobilizing informational resources for rare diseasesMaria Shkrob
 
Digital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient AdvocateDigital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient AdvocateDavid Lee Scher, MD
 

Similar to Slide_Drug information_PharmD Khuê (20)

Clinical Tools - Faculty Development
Clinical Tools - Faculty DevelopmentClinical Tools - Faculty Development
Clinical Tools - Faculty Development
 
ProQuest Dialog - Biomedical Content
ProQuest Dialog - Biomedical ContentProQuest Dialog - Biomedical Content
ProQuest Dialog - Biomedical Content
 
Systematic approach in answering DI queries request
Systematic approach in answering   DI queries requestSystematic approach in answering   DI queries request
Systematic approach in answering DI queries request
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
basic information resource.pptx
basic information resource.pptxbasic information resource.pptx
basic information resource.pptx
 
P1_DI-Principles-and-Practice_student-version.pptx
P1_DI-Principles-and-Practice_student-version.pptxP1_DI-Principles-and-Practice_student-version.pptx
P1_DI-Principles-and-Practice_student-version.pptx
 
Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Webinar pv use case 23 march2016
Webinar pv use case 23 march2016
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
poison and drug info.pdf
poison and drug info.pdfpoison and drug info.pdf
poison and drug info.pdf
 
DRUG INFORMATION.pptx
DRUG INFORMATION.pptxDRUG INFORMATION.pptx
DRUG INFORMATION.pptx
 
Literature monitoring for pharmacovigilance – outsourcing or in house solution
Literature monitoring for pharmacovigilance – outsourcing or in house solutionLiterature monitoring for pharmacovigilance – outsourcing or in house solution
Literature monitoring for pharmacovigilance – outsourcing or in house solution
 
NCompass Live: PubMed, PubMed Central, MEDLINE, MedlinePlus...What's the diff...
NCompass Live: PubMed, PubMed Central, MEDLINE, MedlinePlus...What's the diff...NCompass Live: PubMed, PubMed Central, MEDLINE, MedlinePlus...What's the diff...
NCompass Live: PubMed, PubMed Central, MEDLINE, MedlinePlus...What's the diff...
 
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη ΦαρμακοεπιδημιολογίαΗ συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
 
107 satellife
107 satellife107 satellife
107 satellife
 
Drug information resources
Drug  information resourcesDrug  information resources
Drug information resources
 
Library resources for clinical faculty
Library resources for clinical facultyLibrary resources for clinical faculty
Library resources for clinical faculty
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug information
 
How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...
 
Mobilizing informational resources for rare diseases
Mobilizing informational resources for rare diseasesMobilizing informational resources for rare diseases
Mobilizing informational resources for rare diseases
 
Digital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient AdvocateDigital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient Advocate
 

More from HA VO THI

Development and validation of the Vi-Med ® tool for medication review
Development and validation of the Vi-Med ® tool for medication reviewDevelopment and validation of the Vi-Med ® tool for medication review
Development and validation of the Vi-Med ® tool for medication reviewHA VO THI
 
Bảng tra tương hợp - tương kỵ
Bảng tra tương hợp - tương kỵ Bảng tra tương hợp - tương kỵ
Bảng tra tương hợp - tương kỵ HA VO THI
 
Bảng dị ứng kháng sinh chéo
Bảng dị ứng kháng sinh chéo Bảng dị ứng kháng sinh chéo
Bảng dị ứng kháng sinh chéo HA VO THI
 
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)HA VO THI
 
English for pharmacist
English for pharmacistEnglish for pharmacist
English for pharmacistHA VO THI
 
Độc tính trên da của thuốc trị ung thư
Độc tính trên da của thuốc trị ung thưĐộc tính trên da của thuốc trị ung thư
Độc tính trên da của thuốc trị ung thưHA VO THI
 
Quản lý ADR hóa trị liệu ung thư
Quản lý ADR hóa trị liệu ung thưQuản lý ADR hóa trị liệu ung thư
Quản lý ADR hóa trị liệu ung thưHA VO THI
 
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2HA VO THI
 
Vi-Med tool for medication review - Form 3 - English version
Vi-Med tool for medication review - Form 3 - English versionVi-Med tool for medication review - Form 3 - English version
Vi-Med tool for medication review - Form 3 - English versionHA VO THI
 
Vi-Med tool for medication review - Form 2 - English version
Vi-Med tool for medication review - Form 2 - English versionVi-Med tool for medication review - Form 2 - English version
Vi-Med tool for medication review - Form 2 - English versionHA VO THI
 
Vi-Med tool for medication review - Form 1 - English version
Vi-Med tool for medication review - Form 1 - English versionVi-Med tool for medication review - Form 1 - English version
Vi-Med tool for medication review - Form 1 - English versionHA VO THI
 
Quản lý sử dụng kháng sinh
Quản lý sử dụng kháng sinhQuản lý sử dụng kháng sinh
Quản lý sử dụng kháng sinhHA VO THI
 
Poster - Counseling activities of drug use at community pharmacy in Hue City
Poster - Counseling activities of drug use at community pharmacy in Hue CityPoster - Counseling activities of drug use at community pharmacy in Hue City
Poster - Counseling activities of drug use at community pharmacy in Hue CityHA VO THI
 
Poster- The Vi-Med tool for medication review
Poster- The Vi-Med tool for medication reviewPoster- The Vi-Med tool for medication review
Poster- The Vi-Med tool for medication reviewHA VO THI
 
Thông báo tuyển sinh thạc sĩ DL-DLS tại Huế
Thông báo tuyển sinh thạc sĩ DL-DLS tại HuếThông báo tuyển sinh thạc sĩ DL-DLS tại Huế
Thông báo tuyển sinh thạc sĩ DL-DLS tại HuếHA VO THI
 
Bệnh động mạch chi dưới - khuyến cáo 2010
Bệnh động mạch chi dưới - khuyến cáo 2010Bệnh động mạch chi dưới - khuyến cáo 2010
Bệnh động mạch chi dưới - khuyến cáo 2010HA VO THI
 
Poster “Quản lý thuốc nguy cơ cao”
Poster “Quản lý thuốc nguy cơ cao”Poster “Quản lý thuốc nguy cơ cao”
Poster “Quản lý thuốc nguy cơ cao”HA VO THI
 
Bảng tra tương hợp-tương kỵ
Bảng tra tương hợp-tương kỵBảng tra tương hợp-tương kỵ
Bảng tra tương hợp-tương kỵHA VO THI
 
Bảng dị ứng chéo kháng sinh
Bảng dị ứng chéo kháng sinhBảng dị ứng chéo kháng sinh
Bảng dị ứng chéo kháng sinhHA VO THI
 
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017HA VO THI
 

More from HA VO THI (20)

Development and validation of the Vi-Med ® tool for medication review
Development and validation of the Vi-Med ® tool for medication reviewDevelopment and validation of the Vi-Med ® tool for medication review
Development and validation of the Vi-Med ® tool for medication review
 
Bảng tra tương hợp - tương kỵ
Bảng tra tương hợp - tương kỵ Bảng tra tương hợp - tương kỵ
Bảng tra tương hợp - tương kỵ
 
Bảng dị ứng kháng sinh chéo
Bảng dị ứng kháng sinh chéo Bảng dị ứng kháng sinh chéo
Bảng dị ứng kháng sinh chéo
 
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
 
English for pharmacist
English for pharmacistEnglish for pharmacist
English for pharmacist
 
Độc tính trên da của thuốc trị ung thư
Độc tính trên da của thuốc trị ung thưĐộc tính trên da của thuốc trị ung thư
Độc tính trên da của thuốc trị ung thư
 
Quản lý ADR hóa trị liệu ung thư
Quản lý ADR hóa trị liệu ung thưQuản lý ADR hóa trị liệu ung thư
Quản lý ADR hóa trị liệu ung thư
 
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
 
Vi-Med tool for medication review - Form 3 - English version
Vi-Med tool for medication review - Form 3 - English versionVi-Med tool for medication review - Form 3 - English version
Vi-Med tool for medication review - Form 3 - English version
 
Vi-Med tool for medication review - Form 2 - English version
Vi-Med tool for medication review - Form 2 - English versionVi-Med tool for medication review - Form 2 - English version
Vi-Med tool for medication review - Form 2 - English version
 
Vi-Med tool for medication review - Form 1 - English version
Vi-Med tool for medication review - Form 1 - English versionVi-Med tool for medication review - Form 1 - English version
Vi-Med tool for medication review - Form 1 - English version
 
Quản lý sử dụng kháng sinh
Quản lý sử dụng kháng sinhQuản lý sử dụng kháng sinh
Quản lý sử dụng kháng sinh
 
Poster - Counseling activities of drug use at community pharmacy in Hue City
Poster - Counseling activities of drug use at community pharmacy in Hue CityPoster - Counseling activities of drug use at community pharmacy in Hue City
Poster - Counseling activities of drug use at community pharmacy in Hue City
 
Poster- The Vi-Med tool for medication review
Poster- The Vi-Med tool for medication reviewPoster- The Vi-Med tool for medication review
Poster- The Vi-Med tool for medication review
 
Thông báo tuyển sinh thạc sĩ DL-DLS tại Huế
Thông báo tuyển sinh thạc sĩ DL-DLS tại HuếThông báo tuyển sinh thạc sĩ DL-DLS tại Huế
Thông báo tuyển sinh thạc sĩ DL-DLS tại Huế
 
Bệnh động mạch chi dưới - khuyến cáo 2010
Bệnh động mạch chi dưới - khuyến cáo 2010Bệnh động mạch chi dưới - khuyến cáo 2010
Bệnh động mạch chi dưới - khuyến cáo 2010
 
Poster “Quản lý thuốc nguy cơ cao”
Poster “Quản lý thuốc nguy cơ cao”Poster “Quản lý thuốc nguy cơ cao”
Poster “Quản lý thuốc nguy cơ cao”
 
Bảng tra tương hợp-tương kỵ
Bảng tra tương hợp-tương kỵBảng tra tương hợp-tương kỵ
Bảng tra tương hợp-tương kỵ
 
Bảng dị ứng chéo kháng sinh
Bảng dị ứng chéo kháng sinhBảng dị ứng chéo kháng sinh
Bảng dị ứng chéo kháng sinh
 
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
 

Recently uploaded

Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
CNN-based plastic waste detection system
CNN-based plastic waste detection systemCNN-based plastic waste detection system
CNN-based plastic waste detection systemBOHRInternationalJou1
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Catherine Liao
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)Monika Kanwar
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...KavyasriPuttamreddy
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingMedicoseAcademics
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyDr KHALID B.M
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxgauripg8
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentabdeli bhadarva
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadNephroTube - Dr.Gawad
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxBright Chipili
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxgauripg8
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAkashGanganePatil1
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cancer Institute NSW
 
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxMALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxKhanSabit
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartMedicoseAcademics
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 

Recently uploaded (20)

Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
CNN-based plastic waste detection system
CNN-based plastic waste detection systemCNN-based plastic waste detection system
CNN-based plastic waste detection system
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxMALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 

Slide_Drug information_PharmD Khuê

  • 1. 8/26/14 1 Agenda   •  Icebreaker   •  Drug  informa1on  references   – Categories  of  drug  informa1on  literature   •  Advantages  vs.  Disadvantages   •  Examples   – Some  commonly  used  resources   •  Poten1al  topics  for  future  webinars   Icebreaker   •  Presenters   – Võ  Thị  Hà,  MSPharm.   – Nguyễn  Như  Hồ,  MSPharm.   – Nguyễn  Đức  Như  Khuê,  PharmD/MPH   •  ASendees   To  Wiki  or  Not  to  Wiki?   Categories  of  Drug  Informa6on  Literature   • Primary  literature   • Secondary  literature   • Ter1ary  literature   Primary  Literature   •  Original  “research”  publica1ons.   •  Source  of  informa1on  for  the  development  of  the   secondary  and  ter1ary  literature.   •  Containing  a  detailed  descrip1on  of  study  design,   methodology,  and  results.   •  Research  studies,  case  reports,  editorials,  disserta1ons,   leSers  to  the  editor,  and  randomized  control  trials   published  or  presented  for  the  first  1me.   •  Top  1er  peer  reviewed  journals:  NEJM,  JAMA,  Archives   of  Internal  Medicine,  BMJ,  Pharmacotherapy,  Lancet,   etc…     Primary  Literature  (cont.)   •  Advantages:   – Current,  original,  and  "cucng-­‐edge"  informa1on.     – Pa#ent-­‐oriented  &  evidence-­‐based  medicine  that  can   be  directly  u#lized  to  help  care  for  pa#ents.   – Peer  reviewed,  unbiased  sugges1ons,  and  open  to   cri1ques  and  rebuSals.   •  Disadvantages:   – Inaccurate  conclusions  d/t  flaws  in  methodology   – Improper  interpreta1on  d/t  lack  of  knowledge  about   scien1fic  methods  and  sta1s1cs   – Time  for  new  informa1on  to  be  widely  accepted  
  • 2. 8/26/14 2 Primary  Literature  in  Prac6ce   •  Learn  to  be  cau1ous  with  new  informa1on.   •  Is  the  ar1cle  from  a  peer-­‐reviewed  journal?     •  Understand  study  popula1on,  methods,   sta1s1cal  and  clinical  relevance    to  your  prac1ce   popula1on  before  extrapola1ng  to  your  pa1ent.   •  Remember  case  reports  relate  only  to  one   pa1ent,  watch  for  bias,  and  avoid  relying  on   anecdotes.   Secondary  Literature   •  Indexing  and  abstrac1ng  services.   •  Examples:   – Medline  Database  covers  many  fields  of  medicine   including:  den1stry,  nursing,  veterinary,  pharmacy   and  hard  sciences.   •  PubMed  Medline   •  OVID  Medline   – Iowa  Drug  Informa6on  Service  indexes  English   (full  text)  ar1cles  relevant  to  drugs  and  treatment   of  disease  from  approximately  200  journals.   – Micromedex:  an  extensive  pharmacology   database   Secondary  Literature  (cont.)   •  Advantages:   – Quick  access  to  the  primary  literature.   – Large  scope  of  and/or  concise  informa1on  on   specific  topics   – Generally  from  peer  reviewed  and  high  standard   journal  sources.   •  Disadvantages:   – Lag  1me   – Availability  of  specific  journal   – Large  amount  of  informa1on  –  Search  techniques   – Cost   Ter6ary  Literature   •  Textbooks  e.g.  Goodman  &  Gilman’s   Pharmacological  Basis  of  Therapeu1cs   •  Compendia  (a  vast  array  of  informa1on  about   many  drugs)  e.g.  such  as  Facts  and  Comparisons   •  Review  ar1cles  in  journals  that  thoroughly   summarize  a  par1cular  topic  can  also  be   considered  ter1ary  literature  (usually  more  up  to   date  than  text)   Ter6ary  Literature  (cont.)   •  Advantages:   – Convenient  and  easy  to  use.       – Divided  into  specific  subjects,  e.g.  drug   interac1ons,  drugs  in  pregnancy.   – Informa1on  generally  well  accepted   •  Disadvantages:   – Lag  1me   – Space  limita1on   – Less  thorough  review   – Possible  inappropriate  references   – Flawed  primary  literature  (poorly  done  studies)   Common  Online  Sources  (in  US)   •  FDA  approved  drug  products:   www.accessdata.fda.gov/scripts/cder/drugsarda   •  Dailymed  @  NLM  (database  of  product  package  inserts)  :   www.dailymed.nlm.nih.gov/dailymed     •  Drug  informa1on  portal  @  NLM:   www.druginfo.nlm.nih.gov/drugportal     •  Consumer  page  @  FDA:  www.fda.gov/forconsumers   •  MedlinePlus  @  NIH:  www.nlm.nih.gov/medlineplus   •  FDA  medica1on  guides:  www.fda.gov/drugs/drugsafety/   •  MedWatch:  www.fda.gov/safety/medwatch   •  Medica1on  safety:  www.ismp.org     •  Drug  iden1fica1on:  pillbox.nlm.nih.gov    
  • 3. 8/26/14 3 Common  Online  Sources  (in  US)   •  Diseases  &  Condi1ons  @  CDC:   www.cdc.gov/diseasescondi1ons   •  Travel  medicine:  www.cdc.gov/travel  or  www.iamat.org     •  Na1onal  guideline  clearinghouse:  www.guideline.gov   •  Clinical  trials:  www.clinicaltrials.gov   •  Na1onal  Cancer  Ins1tute:  www.cancer.gov   •  Most  of  cancer  guidelines:  www.nccn.org     •  DM  guideline:  ADA  2013  (less  commonly  used  AACE)   •  HTN:  JNC  8  or  AHA  for  HTN   •  An1thrombo1c  therapy:  CHEST  2012   •  Dyslipidemia:  AHA/ACC  2013  Cholesterol  (aka  “ATP  4”)   •  Be  proac1ve:  look  for  drug  problems.    No  other  healthcare   provider  has  the  unique  opportunity  to  improve  drug  therapy   that  pharmacists  have.   •  Dig  deeper:  oxen  1mes  the  ques1on  that  is  originally  asked  is   not  the  ques1on  the  person  was  trying  to  ask.   •  Be  skillful:  use  a  systema1c,  logical,  organized  approach.   •  Keep  records:  document  your  search  methods  and  answer.   •  There  may  be  more  than  one  correct  answer.       •  An  acceptable  answer  may  be  “I  will  find  out”.   Drug  Informa1on  Pearls